Key indicators: single-crystal X-ray study; T = 113 K; mean (C-C) = 0.003 Å; R factor = 0.041; wR factor = 0.116; data-to-parameter ratio = 12.2.
Experimental
Crystal data Table 1 Hydrogen-bond geometry (Å , ). 
Comment
Tolvaptan is an oral nonpeptide selective vasopressin V 2 -receptor antagonist indicated for the treatment of clinically relevant hypervolemic or euvolemic hyponatremia associated with heart failure, cirrhosis, or syndrome of inappropriate antidiuretic hormone (Nemerovski et al., 2010) . Now, we present the crystal structure of the title compound (I) (Kondo et al., 1999) , an intermediate of Tolvaptan.
In (I) (Fig. 1) , all bond lengths and angles are normal and correspond to those observed in the analougs (Liu et al., 2008) .
The acetoxy and nitro groups attached to the benzene ring at neighbouring positions are twisted from its plane at 49.7 (1) and 29.4 (1)°, respectively. In the crystal structure, weak C-H···O interactions (Table 1) link molecules into layers parallel to (101) plane. Short intermolecular C···O distances of 2.925 (3) Å observed in the structure.
Experimental
To a stirred solution of the 5-chloro-2-nitrobenzoic acid (10 g, 50 mmol) in acetone(60 ml) was added K 2 CO 3 (10.3 g, 74 mmol) and Me 2 SO 4 (6.2 ml, 64.7 mmol). The mixture was heated at reflux for 30 min. The reaction mixture was then poured into an ice-water bath and extracted with ethyl acetate. The organic layer was separated and dried over MgSO 4 .
then the filtrate was concentrate under reduced pressure to afford the methyl ester as a white solid. Pure compound (I) was obstained by crystallizing from methanol. Crystals of (I) suitable for X-ray diffraction were obstained by slow evaporation of an methanol solution.
Refinement
All H atoms were positioned geometrically and refined using a riding model, with d(C-H) = 0.95 -0.99 Å, and U iso (H) = 1.2 or 1.5 U eq . Figures   Fig. 1 . The molecular structure of (I), with the atom-numbering scheme and 50% probability displacement ellipsoids. 
Special details

